Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Infectious: Page 3
NIH researchers develop PCR assay for easier diagnosis of river blindness
By
LabPulse.com staff writers
U.S. National Institutes of Health (NIH) researchers have developed a new PCR assay to detect Onchocerca volvulus, the parasite that causes onchocerciasis, or river blindness, and are working to adapt it for easier field diagnosis of the disease.
October 9, 2023
BioMérieux subsidiary secures DoD contract for infectious disease testing system
By
LabPulse.com staff writers
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Study shows malaria drug resistance occurring in Horn of Africa
By
Maryam Payne
Malaria parasites in eastern Africa have developed resistance to artemisinins, essential first-line drugs used in combination therapies, jeopardizing the progress made in recent decades against the disease.
September 29, 2023
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
By
Nick Paul Taylor
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Some emergency sepsis screening tools inadequate, EU study suggests
By
Matt Limb
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
HIV vaccine trial begins enrollment in U.S., South Africa
By
LabPulse.com staff writers
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Danaher cuts cost of rapid TB test after years of pressure from activists
By
Nick Paul Taylor
Danaher has cut the cost of one of its tuberculosis (TB) tests in less developed countries after years of public pressure to lower the price.
September 21, 2023
Day Zero Diagnostics completes $16M financing round
By
LabPulse.com staff writers
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
NIH starts early-phase trial of second-generation universal flu vaccine candidate
By
Nick Paul Taylor
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
By
LabPulse.com staff writers
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
Moderna’s mRNA flu shot yields promising results in phase III trial
By
LabPulse.com staff writers
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
USP proposes synthetic alternative to horseshoe crab blood in endotoxin testing
By
Nick Paul Taylor
The U.S. Pharmacopoeia (USP) has published draft guidelines on using a synthetic alternative to reagents derived from horseshoe crabs, advancing efforts to provide an alternative way of performing endotoxin testing.
August 31, 2023
Previous Page
Page 3 of 150
Next Page